Search Within

Jaclyn Frances Hechtman

  1. "2017"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (13)
  3. Book Section (1)
Groups
  1. Department of Pathology and Laboratory Medicine (26)
  2. Department of Medicine (19)
  3. Solid Tumor Oncology Division (19)
  4. GSK Faculty (18)
  5. Human Oncology and Pathogenesis Program (17)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (12)

More Groups

People
  1. David Klimstra (13)
  2. Efsevia Vakiani (13)
  3. Jinru Shia (12)
  4. Ahmet Zehir (10)
  5. David Hyman (10)
  6. Marc Ladanyi (10)

More People

Years
  1. 2017 (30)
Publications
  1. Modern Pathology (5)
  2. Laboratory Investigation (4)
  3. Journal of Clinical Oncology (3)
  4. Clinical Cancer Research (2)
  5. American Journal of Surgical Pathology (1)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. Nature Publishing Group (6)
  2. American Association for Cancer Research (5)
  3. Nature Research (5)
  4. American Society of Clinical Oncology (4)
  5. Elsevier Inc. (2)
  6. Oxford University Press (2)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Successful targeted therapy of refractory pediatric ETV6-NTRK3 fusion-positive secretory breast carcinoma
    Journal Article

    Shukla, N.; Roberts, S. S.; Baki, M. O.; Mushtaq, Q.; Goss, P. E.; Park, B. H.; Gundem, G.; Tian, K.; Geiger, H.; Redfield, K.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Clinical and molecular landscape of metastatic colorectal cancer (mCRC) harboring ALK, ROS1, or NTRK 1, 2, 3 (NTRKs) rearrangements
    Meeting Abstract

    Pietrantonio, F.; Di Nicolantonio, F.; Schrock, A. B.; Lee, J.; Tejpar, S.; Siena, S.; Christiansen, J. H.; Hechtman, J. F.; Fucà, G.; Antoniotti, C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Mutational profiling of resected intrahepatic cholangiocarcinoma
    Meeting Abstract

    Pak, L. M.; Goldman, D.; Gonen, M.; Allen, P. J.; Balachandran, V. P.; D'Angelica, M. I.; DeMatteo, R. P.; Kingham, T. P.; Simpson, A.; Hechtman, J. F.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients
    Meeting Abstract

    Ku, G. Y.; Sanchez-Vega, F.; Chatila, W.; Margolis, M.; Fein, C.; Ilson, D. H.; Hechtman, J. F.; Tuvy, Y.; Bouvier, N.; Kundra, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Molecular pathology of pancreatic cancer and premalignant tumors
    Book Section

    Hechtman, J. F.; Iacobuzio-Donahue, C.
    In Jarnagin, W. R.; Allen, P. J.; Chapman, W. C.; D'Angelica, M. I.; DeMatteo, R. P.; Do, R. K. G.; Vauthey, J. N.; Blumgart, L. H. (Eds.) Blumgart's Surgery of the Liver, Biliary Tract and Pancreas. 6th ed (2017)

    Fulltext@MSK | Save
  • Characterization of NTRK fusions and therapeutic response to NTRK inhibition in hematologic malignancies
    Meeting Abstract

    Taylor, J.; Marcelus, C.; Pavlick, D.; Benayed, R.; Yoshimi, A.; Cocco, E.; Durham, B. H.; Hechtman, J. F.; Chung, Y. R.; Mullaney, K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Hybrid-capture based comprehensive genomic profiling of hepatocellular carcinoma identifies patients who may benefit from targeted therapies and immune checkpoint blockade
    Meeting Abstract

    Suh, J.; Severson, E.; Hechtman, J.; Frampton, G.; Fabrizio, D.; Sun, J.; Ali, S.; Gu, P.; Klempner, S.; Miller, V.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • ALK, ROS1, and NTRK rearrangements in metastatic colorectal cancer
    Journal Article

    Pietrantonio, F.; Di Nicolantonio, F.; Schrock, A. B.; Lee, J.; Tejpar, S.; Sartore-Bianchi, A.; Hechtman, J. F.; Christiansen, J.; Novara, L.; Tebbutt, N.; more...
    JNCI: Journal of the National Cancer Institute (2017)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to BRAF V600E inhibition in colon cancers converge on RAF dimerization and are sensitive to its inhibition
    Journal Article

    Yaeger, R.; Yao, Z.; Hyman, D. M.; Hechtman, J. F.; Vakiani, E.; Zhao, H.; Su, W.; Wang, L.; Joelson, A.; Cercek, A.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Real-time genomic profiling of pancreatic ductal adenocarcinoma: Potential actionability and correlation with clinical phenotype
    Journal Article

    Lowery, M. A.; Jordan, E. J.; Basturk, O.; Ptashkin, R. N.; Zehir, A.; Berger, M. F.; Leach, T.; Herbst, B.; Askan, G.; Maynard, H.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save